Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy

Whole blood RNA signatures in tuberculosis patients receiving H56:IC31 vaccine as adjunctive therapy

IntroductionTherapeutic vaccination in tuberculosis (TB) represents a Host Directed Therapy strategy which enhances immune responses in order to improve clinical outcomes and shorten TB treatment. Previously, we have shown that the subunit H56:IC31 vaccine induced both humoral and cellular immune re...

Full description

Bibliographic Details
Main Authors: Noelia Alonso-Rodríguez, Eleonora Vianello, Suzanne van Veen, Synne Jenum, Kristian Tonby, Rosalie van Riessen, Xiaoran Lai, Rasmus Mortensen, Tom H. M. Ottenhoff, Anne Ma Dyrhol-Riise
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Immunology
Subjects:
tuberculosis
H56:IC31 vaccine
host directed therapy
transcriptomics
RNA signature
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1350593/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1350593/full

Similar Items